J. Eugene Huffstutter

The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial

Michael Schiff, C Pritchard, J. Eugene Huffstutter et al. · Annals of the Rheumatic Diseases · 2008 · 154 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

A modified scleroderma skin scoring method.

M. Bashar Kahaleh, GARY L. SULTANY, Edwin A. Smith et al. · PubMed · 1987 · 142 citations

Medicine, Dermatology, Internal Medicine +14

Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.

William Shergy, Reuben A. Isern, David A. Cooley et al. · PubMed · 2002 · 70 citations

Medicine, Pharmacology, Pharmacotherapy +13

Cellular immunity to collagen and laminin in scleroderma

J. Eugene Huffstutter, Frank DeLustro, E. Carwile LeRoy · Arthritis & Rheumatism · 1985 · 53 citations

Medicine, Dermatology, Immunology +15

The Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy

Jeffrey R. Curtis, Stacey S. Cofield, S. Louis Bridges et al. · Annals of Internal Medicine · 2021 · 38 citations

Veterinary Medicine, Immunology, Infectious Diseases +17